Overview:

The global stroke diagnostics and therapeutics market is valued for more than US$ XXX.X Mn in 2019 and expected to reach a value of US$ XXX.X Mn by 2029 with a significant CAGR of around XX.X% over the forecast period of 2019-2029. Stroke is a brain attack and it happens when blood flow to the brain is reduced or stopped. In this condition brain cells dies, due to insufficient supply of oxygen as well as nutrients to brain. It can happens at any time to anyone and its types are hemorrhagic, transient ischemic attacks, and ischemic.

Market Dynamics:

Growing number of patients at risk of developing stroke across the globe is a leading factor driving growth of the global stroke diagnostics and therapeutics market. Additionally, increased health care expenditure is another factor propelling growth of the global market. Further, increasing research and development in the healthcare field and growth in the technological advancements in the devices that are used in stroke treatment are other factors expected to propel growth of the global market.

In addition, rising unhealthy diet habit among individuals across the globe and lack of physical exercise are some other factors resulting in growth of the target market. Also, growing geriatric population in developed and developing countries is another key factor supporting growth of the target market.

Furthermore, growing awareness among the patients regarding stroke prevention is playing a vital role in the industry growth. Many educational and awareness campaigns are implemented by the government and key market companies to raise awareness among doctors, patients, and healthcare professionals for the treatment of stroke. This in turn expected to support growth of the global market during the forecast period.

Key Trends:

Rising focus on strategic tie-ups and partnerships among key players is a key trend witnessed in the global stroke diagnostics and therapeutics market. For example, in 2019, Medfield Diagnostics AB and MEYTEC GmbH has agreed to join together to offer the efficient integrated pre-hospital solutions for improvement of diagnosis and treatment of acute stroke.

Regional Analysis:

For detailed understanding of market dynamics, the global stroke diagnostics and therapeutics market is analyzed across key regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America is accounted for the highest market share in 2018, owing to rising number of individuals at stroke risk in the region. For instance, as per the data published by American Heart Association, around 103 Mn adults in the US were suffering from high blood pressure in 2018 and the count is increasing at a high rate.

The market in Asia Pacific region is expected to witness highest growth in terms of CAGR over the forecast period. This is due to rising population and growing stress level among working population in countries in the region.

Scope of the Report:

Detailed Segmentation:

Global Stroke Diagnostics and Therapeutics Market, By Type:

• Diagnostics
• Therapeutics

Global Stroke Diagnostics and Therapeutics Market, By Diagnostics:

• Magnetic Resonance Imaging (MRI)
• Computed Tomography Scan (CTscan)
• Electrocardiography
• Carotid Ultrasound
• Cerebral Angiography
• Others

Global Stroke Diagnostics and Therapeutics Market, By Therapeutics:

• Tissue Plasminogen Activator
• Antiplatelet
• Antihypertensive
• Anticoagulant

Global Stroke Diagnostics and Therapeutics Market, By Application:

• Hemorrhagic Stroke
• Ischemic Stroke

Key Players Covered:

Key players operating in the global market include, Medtronic plc, Cerebrotech Medical Systems, Inc., Boston Scientific Corporation, Cordis Corporation, Neural Analytics, Koninklijke Philips N.V., Medfield Diagnostics, GE Healthcare, Samsung Neurologica, Siemens AG, and Stryker Corporation.

Key Features of the Study:

Foresight Market Research provides detailed analysis on global market in our report- Global Stroke Diagnostics and Therapeutics Market by type, diagnostics, therapeutics, application, and region. The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, and regional outlook. The report delivers competitive analysis about leading players in the global stroke diagnostics and therapeutics market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, market expansion, and marketing tactics used overall the globe.